SUMO-1, Human, mAb 1B12-E2,Hycult Biotech,HM2327

Post-translational modification regulated by conjugation of a small ubiquitin-like modifier (SUMO) is involved in various cellular processes such as transcriptional regulation, apoptosis and nuclear transport. Recent proteomic analyses in mammalian cells revealed that a number of SUMO substrates and specific modifications by SUMO-1 are involved in essential processes, including chromatin organization, transcription, RNA metabolism, immunomodulation and development of the innate immune system.

Host

Human

Platform ID

BAB198684110

Hycult Biotech

Headquarters

Frontstraat 2a 5405 PB Uden, The Netherlands

Contact

Tel: +31 (0)413 251335
Fax: +31(0)413 248353

Product Specifications

Specifications

NameSUMO-1, Human, mAb 1B12-E2
Cat. No.HM2327
HostHuman
IsotypeMouse IgG3
Formulation0.2 ml (100 µg/ml) 0.2 µm filtered antibody solution in PBS, containing 0.1% bovine serum albumin and 0.02% sodium azide.
StorageProduct should be stored at 4°C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
Regulatory StatusResearch Use Only

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.